Vitae 2026, a hallmark event recognizing research excellence across University of Utah Health, featured six rising-star ...
The Neurobiochemistry Laboratory at the Neurosciences Centre (NSC), All India Institute of Medical Sciences (AIIMS), has launched specialised Therapeutic Drug Monitoring (TDM) services for the ...
Chandigarh: A multicentric study across Punjab and Chandigarh has flagged high levels of non-medical use and dependence on ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Free Webinar: Fraud on the Line—Phone & Text Scams, May 18, 3 ...
Filana Therapeutics, Inc.: Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company currently focused on developing therapies for Tuberous ...
Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on ...
An Austin man has pleaded guilty to a manslaughter charge for supplying fentanyl to a woman the day before she was found dead ...
Presentation described the biological rationale for the evaluation of simufilam in TSC-related epilepsyAUSTIN, Texas, May 05, ...
The global burden of epilepsy and seizure disorders has stimulated ongoing efforts to discover novel anticonvulsant agents with enhanced efficacy and safety profiles. Medicinal chemistry strategies ...
Epilepsy affects over 65 million people worldwide and one third of patients exhibit resistance to current therapies, driving a persistent need for novel anticonvulsant agents. Preclinical research ...
Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results